Abstract:Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system (CNS) due to an increase of abnormal peripherally auto-reactive T lymphocytes which elicit autoimmunity. The main pathophysiology of MS is myelin sheath damage by immune cells and a defect in the generation of myelin by oligodendrocytes. Macroautophagy/autophagy is a critical degradation process that eliminates dysfunctional or superfluous cellular components. Autophagy has the property of a double-edged sword in MS in that it may have both beneficial and detrimental effects on MS neuropathology. Therefore, this review illustrates the protective and harmful effects of autophagy with regard to this disease. Autophagy prevents the progression of MS by reducing oxidative stress and inflammatory disorders. In contrast, over-activated autophagy is associated with the progression of MS neuropathology and in this case the use of autophagy inhibitors may alleviate the pathogenesis of MS. Furthermore, autophagy provokes the activation of different immune and supporting cells that play an intricate role in the pathogenesis of MS. Autophagy functions in the modulation of MS neuropathology by regulating cell proliferation related to demyelination and remyelination. Autophagy enhances remyelination by increasing the activity of oligodendrocytes, and astrocytes. However, autophagy induces demyelination by activating microglia and T cells. In conclusion, specific autophagic activators of oligodendrocytes, and astrocytes, and specific autophagic inhibitors of dendritic cells (DCs), microglia and T cells induce protective effects against the pathogenesis of MS. Abbreviations: ALS: amyotrophic lateral sclerosis; APCs: antigen-presenting cells; BBB: blood-brain barrier; CSF: cerebrospinal fluid; CNS: central nervous system; DCs: dendritic cells; EAE: experimental autoimmune encephalomyelitis; ER: endoplasmic reticulum; LAP: LC3-associated phagocytosis; MS: multiple sclerosis; NCA: non-canonical autophagy; OCBs: oligoclonal bands; PBMCs: peripheral blood mononuclear cells; PD: Parkinson disease; ROS: reactive oxygen species; UPR: unfolded protein response

Reactive nitrogen species as therapeutic targets for autophagy/mitophagy modulation to relieve neurodegeneration in multiple sclerosis: Potential application for drug discovery

Nitration of Drp1 Provokes Mitophagy Activation Mediating Neuronal Injury in Experimental Autoimmune Encephalomyelitis

Reactive nitrogen species as therapeutic targets for autophagy: implication for ischemic stroke

Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis

Role of autophagy in the pathogenesis of multiple sclerosis

Radix Rehmanniae Extract Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing Macrophage-Derived Nitrative Damage

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

The beneficial role of autophagy in multiple sclerosis: Yes or No?

Enhancing CNS mitophagy: drug development and disease-relevant models

Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches

Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis

Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis

Autophagy Modulation in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

A Reactive Oxygen Species‐Responsive Targeted Nanoscavenger to Promote Mitophagy for the Treatment of Alzheimer's Disease

Autophagy in Multiple Sclerosis: Phagocytosis and Autophagy of Oligodendrocyte Precursor Cells

Reactive Oxygen Species and Neurodegenerative Diseases: Insights into Nanozyme Therapeutics

The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases

Impaired metabolism of oligodendrocyte progenitor cells and axons in demyelinated lesion and in the aged CNS

Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials

The neuropathobiology of multiple sclerosis